WASHINGTON — Stock in Gaithersburg, Maryland-based vaccine maker Novavax plunged 86 percent in early Friday trading after reporting disappointing late-stage clinical trial results for one of its drug ...
GAITHERSBURG, Md., May 12, 2023 /PRNewswire/ -- Novavax, Inc. (NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Singapore Health ...
CNN — Novavax on Monday announced the start of the Phase 3 trial of its Covid-19 vaccine in the United States and Mexico. It is the fifth company to launch a large-scale trial of a coronavirus vaccine ...
(Reuters) - Top executives at U.S. pharmaceutical company Novavax Inc aren't waiting to see how well their COVID-19 vaccine works before they reap the financial rewards. Chief Executive Stanley Erck ...
(Reuters) -Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a potential sale, and warned it could launch a proxy fight if no ...
GAITHERSBURG, Md., Jan. 20, 2026 /PRNewswire/ -- Novavax, Inc. has entered into a license agreement with Pfizer for use of Novavax's Matrix-M ® adjuvant. Under the terms of the agreement, Pfizer will ...
The court's action allows the administration for now to continue withholding about $4 billion from the Supplemental Nutrition Assistance Program. Reuters, the news and media division of Thomson ...
The MarketWatch News Department was not involved in the creation of this content. -- Non-exclusive license allows for development by Pfizer to utilize Matrix-M(R) for up to two disease areas with its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results